RecruitingNot ApplicableNCT06345963

Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1)


Sponsor

The University of Texas Health Science Center, Houston

Enrollment

120 participants

Start Date

May 21, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Patients with schizophrenia spectrum disorder (SSD) will be exposed to active repetitive transcranial magnetic stimulation (rTMS) from H coil for improving white matter integrity.


Eligibility

Min Age: 18 YearsMax Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This study uses a brain stimulation technique called TMS (transcranial magnetic stimulation) to try to improve brain connectivity and symptoms in people with schizophrenia. TMS delivers gentle magnetic pulses to the scalp to activate specific brain regions without surgery. **You may be eligible if...** - You are between 18 and 60 years old - You have been diagnosed with schizophrenia or a related condition - You are able to give informed consent **You may NOT be eligible if...** - You have a history of seizures - You have an unstable or acute medical condition affecting the brain (such as a recent stroke, brain tumor, or serious head injury) - You are taking more than 400 mg of clozapine per day - You have a device in your body (such as a pacemaker or metal implant in the head) that is not compatible with TMS Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEactive H-coil delivered rTMS

Multiple trains of rTMS in a day, for multiple days.


Locations(1)

The University of Texas Health Science Center, Houston

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06345963


Related Trials